SCRIB and cancer: This observation is not completely surprising as SCRIB overexpression is seen in a number of cancers, with mislocalisation usually favoring a mesenchymal phenotype (Vaira et al., 2011), and perhaps SCRIB overexpression begins in later stages of HPV associated malignant disease.